Reify Health

Reify Health, founded in 2010, is a prominent player in the healthcare software industry, specializing in clinical trial operations. The company focuses on accelerating the delivery of new therapies by streamlining research workflows. Through its unified technology platform, OneStudyTeam, Reify Health connects sponsors, clinical sites, and patients to foster collaboration and improve trial efficiency. Their initiatives, such as Care Access, are specifically designed to expand clinical trial participation within underserved communities, addressing critical barriers in modern medical research.

Operating with a workforce of 500-1,000 employees, Reify Health maintains a robust organizational structure dedicated to software development and design. The company leverages cloud-based solutions to manage complex clinical trial ecosystems, ensuring high performance and data integrity. Meet Reify Health's team to understand the leadership driving these technological advancements and their commitment to operational excellence in the life sciences sector. Their platform serves as a critical bridge in the clinical research lifecycle, enabling stakeholders to navigate regulatory and operational challenges with greater agility.

Financially, Reify Health has demonstrated significant growth, supported by multiple funding rounds, including a $220.0M Series D investment. With annual revenue reaching $189.0M, the company continues to scale its market presence against competitors like Veeva and Signant Health. Explore financial highlights to review their capital structure and historical funding milestones. By prioritizing innovation in clinical trial management, Reify Health remains a key contributor to the global healthcare technology landscape, consistently delivering scalable software solutions that enhance the speed and efficacy of therapeutic development.